About 25% of Medafor stock has been in the hands of people who have had a different point of view, or more likely, a conflict of interest with the majority of Medafor shareholders and current management. It is likely that the 11% of shares acquired from shareholders came largely from this group. Also, this group probably has many different agendas, like becoming old for example. This was the same group that voted against management 2-3 years ago when there was a proxy fight. The unhappy shares have simply changed hands, that is all.